Dermal Fillers Market – Scenario
Dermal Fillers refers to the corrective measures taken to treat facial deformities, natural (by birth) or occurred due to the accident, surgery or even due to the aging. Hyaluronic acid is a naturally occurring substance in the skin that helps provide fullness and elasticity. It diminishes with age, causing the skin to lose volume while increasing the chances for wrinkles to appear. In such a scenario one needs more than makeup and topical anti-aging creams to turn back the effects of time.
Hence, these facial injectables (dermal fillers) have come into practice to plump up the skin, enhancing the overall youthfulness of facial appearance. Sounding so easy to perform, dermal fillers are far beyond than supplementing facial volume and filling in the creases like wrinkles and folds. Hence, they are performed by the experts/ cosmetic surgeons only. Over the last decade, there has been a significant rise in the number of Dermal Fillers treatments performed worldwide.
The probable factors persuading this rise are the influence of media, fashion and film industry peer pressure for appearance and beauty, and changing dynamics of beauty, etc. Nonetheless, this rise has created a full-fledged, exclusive market space for dermal fillers. Once considered as a part of the cosmetic surgery, Dermal Fillers treatments are a mainstream market now. That too a flourishing market, needless to say.
Request for Sample Report at https://www.marketresearchfuture.com/sample_request/3893
Acknowledging the value this market is garnering currently and the growth prospect the market is demonstrating worldwide, Market Research Future (MRFR), recently published a brilliant study report giving out the complete market prognosis up till 2023. According to MRFR, the Global Dermal Fillers market is expected to accrue USD 10,008.4 Mn. by 2023, registering ~12.5% CAGR during the forecasted period (2017 -2023).
Augmenting demand for Dermal Fillers treatments and the introduction of advanced technology in the facial rejuvenation industry predominantly drives the global market growth. The growth of the medical tourism market and formation of tourism clusters such as Miami, Bangkok, etc. has not only provided exposure to Dermal Fillers but have also created a high point demand for these treatments.
Additional factors such as the growing population, the geriatric populace and urbanization worldwide are fueling the market growth. Evidently, improving economic conditions that enable access to the quality life & the improved healthcare worldwide are the key driving force, providing impetus to the market growth. Moreover, factors such as the growing prevalence of obesity, accidents, along with the growing number of Dermal Fillers hospitals and the safety margin these facilities offer, in turn, fuel the market growth.
Dermal Fillers Market – Key players:
Dr. Korman Laboratories
And Teoxane laboratories.
Dermal Fillers Market – Segmentation:
The MRFR analysis is segmented into four key dynamics for the convenience of the report and enhanced understanding;
By Types: Botulinum Toxin, Hyaluronic Acid, Polymers & Particles, and Collagen among others.
By Applications: Facial Line Correction Treatment, and Face-Lift, Lip Treatments, among others.
By Regions: North America, Europe, APAC and Rest of the World.
The Botulinum toxin segment accounted for the largest market share in the Global Dermal Filler Market while the Hyaluronic Acid segment will grow at 13% CAGR during the forecast period (2017 – 2023).
The Facial line correction treatment segment accounted for the largest market share in the dermal filler market by application; the segment is further expected to garner US$ 4,319 Mn. by 2023.
Dermal Fillers Market – Regional Analysis
Geographically, North America accounts for the leading market for Dermal Fillers, possessing the largest market share, followed by Europe & Asia Pacific markets, respectively.
Attributing to the largest contribution from the significantly growing US market the market is growing constantly. The US market is backed by the high expenditure spent on the Dermal Fillers & health care.
Huge investments put into R&D and technologically advanced products, have paid off well and escalating the US dermal fillers market to the valuation at USD 1,074.0 Mn. in 2016. Continuing with the same growth trends, the North America market is likely to retain its dominance during the review period, reaching over 3,700 Mn. USD by 2023.
On the other hand, the world’s second-largest market for dermal fillers, Europe, is driven by the high per capita income and strong healthcare penetration in the region. The strong market growth in the countries like Germany & France drives the regional market growth on a large scale.
Owing to the wide uptake of new products and advanced therapies, the Europe market is expected to reach over USD 10,000 Mn. by 2023. France, among the other European countries, accounts for the leading market while the UK accounts for the fastest growing dermal fillers market.
The Asia Pacific dermal fillers market has emerged as one of the promising markets, growing rapidly due to the rapidly widening awareness towards these aesthetic treatments, and improving per capita healthcare expenditures. The APAC market is expected to perceive an exponential growth over the forecast period while China and India will be taking the lead owing to the huge population and the burgeoning medical treatment market in the region. Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the regional market growth owing to the medical tourism in the region.
July 17, 2018 – Northside Plastic Surgery (US), one of the leading Clinics active into body aesthetic treatments introduced its newest FDA-approved hyaluronic acid (HA) dermal filler – Restylane Lyft for the correction of volume loss in aging hands. It is the first and only HA dermal filler to receive FDA approval for an area other than the face.
July 13, 2018 – Nept Holdings sarl, (Poland), one of the leading property and M & A Navigator Company and a subsidiary of Abris CEE Mid-Market Fund III LP, a PE fund managed by Abris Capital Partners Ltd., announced the acquisition of a strategic stake in ITP S.A., (Poland), a dynamically growing company operating on the aesthetic medicine, beauty, fitness and wellness markets. ITP S.A. owns the Neauvia brand, which is a new generation of hyaluronic acid dermal fillers and a line of professional cosmeceuticals currently worldwide.
Ask Any Question at https://www.marketresearchfuture.com/enquiry/3893
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar